• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后头痛患者的“红色警报”频率和类型:104 例住院患者系列。

Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients.

机构信息

Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

出版信息

Headache. 2020 Sep;60(8):1664-1672. doi: 10.1111/head.13927. Epub 2020 Aug 18.

DOI:10.1111/head.13927
PMID:32790215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7436570/
Abstract

OBJECTIVE

In this study, we aimed to evaluate the frequency of the main red flags in patients with headache who do have Covid-19.

BACKGROUND

Headache is one of the most frequent neurologic symptoms of Coronavirus disease 2019 (Covid-19). Diagnosis of secondary headache disorders is still based on the presence of red flags.

DESIGN AND METHODS

Cross-sectional study of hospitalized patients with confirmed Covid-19 disease. We interrogated every patient about the presence of headache and if so, a headache expert conducted a structured interview assessing the presence and type of the main red flags. We evaluated the presence of laboratory abnormalities on admission.

RESULTS

We screened 576 consecutive patients, 130/576 (22.6%) described headache, and 104 were included in the study. Mean age of patients was 56.7 (standard deviation: 11.2) and 66/104 (63.4%) were female. Red flags concerning prior medical history were present in 79/104 (76.0%) cases, and those related to the headache itself were observed in 99/104 (95.2%) patients. All patients 104/104 (100%) described systemic symptoms and 86/104 (82.7%) some neurologic symptoms. Laboratory results were abnormal in 98/104 (94.2%) cases. The most frequent red flags were fever, in 93/104 (89.4%) patients, cough, in 89/104 (85.6% cases), and increased C-reactive protein in 84/100 (84.0%) cases.

CONCLUSION

In patients with Covid-19 that described the headache red flags were present in most cases. There was not any universal red flag, being necessary the comprehensive evaluation of all of them.

摘要

目的

本研究旨在评估患有新冠肺炎的头痛患者主要体征的出现频率。

背景

头痛是 2019 年冠状病毒病(COVID-19)最常见的神经系统症状之一。继发性头痛疾病的诊断仍基于体征的存在。

设计和方法

对确诊为 COVID-19 住院患者进行横断面研究。我们询问每位患者是否存在头痛,如果有,由头痛专家进行结构化访谈,评估主要体征的存在和类型。我们评估入院时的实验室异常情况。

结果

我们共筛查了 576 例连续患者,其中 130/576(22.6%)描述了头痛,104 例纳入了研究。患者的平均年龄为 56.7(标准差:11.2),其中 66/104(63.4%)为女性。79/104(76.0%)例有既往病史相关体征,99/104(95.2%)例有头痛相关体征。所有患者 104/104(100%)均有全身症状,86/104(82.7%)例有神经系统症状。98/104(94.2%)例实验室结果异常。最常见的体征是发热,93/104(89.4%)例,咳嗽,89/104(85.6%)例,C 反应蛋白升高 84/100(84.0%)例。

结论

在描述头痛的 COVID-19 患者中,大多数患者存在体征。没有任何普遍的体征,需要对所有体征进行全面评估。

相似文献

1
Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients.新冠病毒感染后头痛患者的“红色警报”频率和类型:104 例住院患者系列。
Headache. 2020 Sep;60(8):1664-1672. doi: 10.1111/head.13927. Epub 2020 Aug 18.
2
Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals.与 SARS-CoV-2 感染相关的头痛谱:医护专业人员研究。
Headache. 2020 Sep;60(8):1697-1704. doi: 10.1111/head.13902. Epub 2020 Jul 15.
3
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry.新型冠状病毒肺炎的神经系统表现:来自西班牙神经病学学会神经 COVID-19 登记处的研究结果。
J Neurol Sci. 2021 Apr 15;423:117283. doi: 10.1016/j.jns.2020.117283. Epub 2020 Dec 19.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
5
Case Series of Headache Characteristics in COVID-19: Headache Can Be an Isolated Symptom.COVID-19 相关头痛特征的病例系列:头痛可能是孤立的症状。
Headache. 2020 Sep;60(8):1788-1792. doi: 10.1111/head.13940. Epub 2020 Aug 17.
6
Headache as the Presenting Symptom in 2 Patients With COVID-19 and a History of Migraine: 2 Case Reports.COVID-19 病史患者头痛为首发症状 2 例:2 例病例报告
Headache. 2020 Sep;60(8):1773-1776. doi: 10.1111/head.13890. Epub 2020 Jul 3.
7
Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study.头痛为 2019 冠状病毒病的主要症状:一项横断面研究。
Headache. 2020 Nov;60(10):2176-2191. doi: 10.1111/head.13967. Epub 2020 Sep 28.
8
Characterization of Headache in COVID-19: a Retrospective Multicenter Study.COVID-19 相关头痛特征:一项回顾性多中心研究。
Mol Neurobiol. 2021 Sep;58(9):4487-4494. doi: 10.1007/s12035-021-02430-w. Epub 2021 May 25.
9
Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.伊朗马什哈德医科大学的一项横断面研究:严重 COVID-19 感染的人口统计学和临床特征。
BMC Infect Dis. 2021 Jul 7;21(1):656. doi: 10.1186/s12879-021-06363-6.
10
Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study.与住院 COVID-19 患者头痛存在相关的因素及其对预后的影响:一项回顾性队列研究。
J Headache Pain. 2020 Jul 29;21(1):94. doi: 10.1186/s10194-020-01165-8.

引用本文的文献

1
Significance of Neurological Manifestations and Their Association With Clinical Outcomes in Hospitalized COVID-19 Patients in Bandar Abbas, Iran: A Cross-Sectional Study.伊朗阿巴斯港住院COVID-19患者神经学表现的意义及其与临床结局的关联:一项横断面研究
Health Sci Rep. 2025 Apr 18;8(4):e70723. doi: 10.1002/hsr2.70723. eCollection 2025 Apr.
2
Knowledge of Headache Red Flags among the General Population of Saudi Arabia: A Comprehensive Evaluation.沙特阿拉伯普通人群对头痛警示信号的认知:一项综合评估。
Ann Afr Med. 2025 Apr 1;24(2):398-405. doi: 10.4103/aam.aam_254_24. Epub 2025 Mar 4.
3
Persistent headache after COVID-19: Pathophysioloy, clinic and treatment.新冠病毒感染后持续性头痛:病理生理学、临床及治疗
Neurol Perspect. 2021 Dec;1:S31-S36. doi: 10.1016/j.neurop.2021.10.003. Epub 2021 Dec 14.
4
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.与 SARS-CoV-2 感染和疫苗接种相关的头痛和面部疼痛:系统评价。
Eur J Neurol. 2024 Jun;31(6):e16251. doi: 10.1111/ene.16251. Epub 2024 Feb 28.
5
New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study.新型冠状病毒感染后新发持续性每日头痛:一项横断面研究。
BMC Infect Dis. 2023 Dec 14;23(1):877. doi: 10.1186/s12879-023-08898-2.
6
Differences and similarities between COVID-19 related-headache and COVID-19 vaccine related-headache. A case-control study.新型冠状病毒相关头痛与新型冠状病毒疫苗相关头痛的差异和相似之处。一项病例对照研究。
Rev Neurol. 2023 Nov 16;77(10):229-239. doi: 10.33588/rn.7710.2023063.
7
Headache in COVID-19 and Long COVID: to Know Facts for Clinical Practice.新冠病毒感染及新冠后综合征中的头痛:临床实践需了解的事实
Curr Neurol Neurosci Rep. 2023 Oct;23(10):551-560. doi: 10.1007/s11910-023-01296-w. Epub 2023 Sep 4.
8
Unusual Presentation of COVID-19 Headache and Its Possible Pathomechanism.新型冠状病毒肺炎头痛的不寻常表现及其可能的发病机制
Cureus. 2022 Sep 20;14(9):e29358. doi: 10.7759/cureus.29358. eCollection 2022 Sep.
9
Post-COVID Headache: A Literature Review.新冠后头痛:文献综述。
Curr Pain Headache Rep. 2022 Nov;26(11):835-842. doi: 10.1007/s11916-022-01086-y. Epub 2022 Oct 5.
10
A bibliometric analysis of COVID-19 publications in neurology by using the visual mapping method.采用可视化图谱方法对神经病学领域 COVID-19 文献进行的计量学分析。
Front Public Health. 2022 Jul 26;10:937008. doi: 10.3389/fpubh.2022.937008. eCollection 2022.

本文引用的文献

1
Reply to letter on Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study.关于新型冠状病毒肺炎背景下急性起病的嗅觉和味觉障碍的回复信:一项基于聚合酶链反应的多中心试点病例对照研究
Eur J Neurol. 2020 Sep;27(9):e34. doi: 10.1111/ene.14359. Epub 2020 Jul 7.
2
Managing Migraine in the Times of COVID-19 Pandemic.在新冠疫情时代应对偏头痛
Ann Indian Acad Neurol. 2020 Apr;23(Suppl 1):S33-S39. doi: 10.4103/aian.AIAN_296_20. Epub 2020 Apr 20.
3
Headaches During COVID-19: My Clinical Case and Review of the Literature.COVID-19 期间的头痛:我的临床病例与文献回顾。
Headache. 2020 Jul;60(7):1422-1426. doi: 10.1111/head.13841. Epub 2020 May 15.
4
COVID-19 is a Real Headache!COVID-19 真是让人头疼!
Headache. 2020 Jul;60(7):1415-1421. doi: 10.1111/head.13856. Epub 2020 May 27.
5
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases.新冠病毒感染者嗅觉丧失和味觉丧失的客观评估:72 例患者的单中心经验。
Head Neck. 2020 Jun;42(6):1252-1258. doi: 10.1002/hed.26204. Epub 2020 Apr 29.
6
Headache medication and the COVID-19 pandemic.头痛药物与 COVID-19 大流行。
J Headache Pain. 2020 Apr 25;21(1):38. doi: 10.1186/s10194-020-01106-5.
7
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).冠状病毒病19(COVID-19)与非甾体抗炎药(NSAID)
Ann Rheum Dis. 2021 Feb;80(2):e12. doi: 10.1136/annrheumdis-2020-217598. Epub 2020 Apr 22.
8
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
9
Migraine in the Time of COVID-19.新冠疫情时期的偏头痛
Headache. 2020 May;60(5):988-989. doi: 10.1111/head.13803. Epub 2020 Apr 8.
10
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病(COVID-19)轻至中度形式的临床特征:一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.